Arielle H Spellun1, Christopher J Moreland2, Poorna Kushalnagar3. 1. Boston Combined Residency Program, Boston Children's Hospital Department of Medicine, Boston Medical Center, Department of Pediatrics, Boston, Massachusetts. 2. Department of Internal Medicine, University of Texas Health San Antonio, San Antonio, Texas. 3. Department of Psychology, Gallaudet University, Washington, DC. Electronic address: Poorna.kushalnagar@gallaudet.edu.
Abstract
STUDY OBJECTIVE: To describe knowledge and risk perception of human papillomavirus (HPV) among deaf adults who use American sign language (ASL) comparison with hearing adults in the United States. DESIGN: Secondary HPV knowledge data for the deaf subset sample were drawn from the Health Information National Trends survey in ASL that was administered between 2015 and 2018. HPV knowledge data for the hearing subset sample were drawn from cycle 5 of the Health Information National Trends survey in English that was administered in 2017. SETTING: Surveys are a nationally based survey of deaf ASL users in the United States and a nationally based survey of hearing non-ASL users in the United States. PARTICIPANTS: The age of the deaf and hearing subset samples was determined on the basis of catchup vaccine eligibility criteria as outlined by the Centers for Disease Control and Prevention that recommends catchup vaccination in women, men who have sex with men, immunocompromised individuals, and those who identify as transgender. INTERVENTIONS AND MAIN OUTCOME MEASURES: We examined HPV, HPV vaccine, and HPV-related cancer knowledge in deaf and hearing subsets. RESULTS: Our sample consisted of 235 deaf and 115 hearing adults aged 18-26 years. Of the deaf participants 58% (136/235) reported knowledge of HPV compared with 84% (97/115) of hearing participants (P < .001). Hearing participants showed higher accuracy in risk perception of HPV relation to cervical cancer compared with deaf participants (P < .001). Hearing participants were more likely to have heard of the HPV vaccine as well as believe it is successful in preventing cervical cancer compared with deaf participants (P < .001). CONCLUSION: Deaf ASL users are less likely to have knowledge of HPV, virus-related cancer risk, and preventative vaccination compared with hearing peers. Published by Elsevier Inc.
STUDY OBJECTIVE: To describe knowledge and risk perception of human papillomavirus (HPV) among deaf adults who use American sign language (ASL) comparison with hearing adults in the United States. DESIGN: Secondary HPV knowledge data for the deaf subset sample were drawn from the Health Information National Trends survey in ASL that was administered between 2015 and 2018. HPV knowledge data for the hearing subset sample were drawn from cycle 5 of the Health Information National Trends survey in English that was administered in 2017. SETTING: Surveys are a nationally based survey of deaf ASL users in the United States and a nationally based survey of hearing non-ASL users in the United States. PARTICIPANTS: The age of the deaf and hearing subset samples was determined on the basis of catchup vaccine eligibility criteria as outlined by the Centers for Disease Control and Prevention that recommends catchup vaccination in women, men who have sex with men, immunocompromised individuals, and those who identify as transgender. INTERVENTIONS AND MAIN OUTCOME MEASURES: We examined HPV, HPV vaccine, and HPV-related cancer knowledge in deaf and hearing subsets. RESULTS: Our sample consisted of 235 deaf and 115 hearing adults aged 18-26 years. Of the deaf participants 58% (136/235) reported knowledge of HPV compared with 84% (97/115) of hearing participants (P < .001). Hearing participants showed higher accuracy in risk perception of HPV relation to cervical cancer compared with deaf participants (P < .001). Hearing participants were more likely to have heard of the HPV vaccine as well as believe it is successful in preventing cervical cancer compared with deaf participants (P < .001). CONCLUSION: Deaf ASL users are less likely to have knowledge of HPV, virus-related cancer risk, and preventative vaccination compared with hearing peers. Published by Elsevier Inc.
Entities:
Keywords:
American sign language; Cancer; Deaf; Deafness; Hard of hearing; Human papillomavirus; Vaccine; Young adults
Authors: Michael M McKee; Michael K Paasche-Orlow; Paul C Winters; Kevin Fiscella; Philip Zazove; Ananda Sen; Thomas Pearson Journal: J Health Commun Date: 2015
Authors: Erika L Thompson; Cheryl A Vamos; Coralia Vázquez-Otero; Rachel Logan; Stacey Griner; Ellen M Daley Journal: Prev Med Date: 2016-02-08 Impact factor: 4.018
Authors: Kelly D Blake; Allison J Ottenbacher; Lila J Finney Rutten; Meredith A Grady; Sarah C Kobrin; Robert M Jacobson; Bradford W Hesse Journal: Am J Prev Med Date: 2015-02-18 Impact factor: 5.043
Authors: David E Nelson; Gary L Kreps; Bradford W Hesse; Robert T Croyle; Gordon Willis; Neeraj K Arora; Barbara K Rimer; K V Viswanath; Neil Weinstein; Sara Alden Journal: J Health Commun Date: 2004 Sep-Oct